Hormone-responsive, patient-derived models of the uterine wall in a microfluidic array

Tools

Busch, Caroline and Hill, Christopher J. and Paterson, Karla and Zagnoni, Michele and Hapangama, Dharani and Sandison, Mairi E. (2024) Hormone-responsive, patient-derived models of the uterine wall in a microfluidic array. In: Tissue and Cell Engineering Society Conference 2024, 2024-06-19 - 2024-06-21.

[thumbnail of Busch-etal-TCES-2024-Hormone-responsive-patient-derived-models-of-the-uterine-wall]
Preview
 Text. Filename: Busch-etal-TCES-2024-Hormone-responsive-patient-derived-models-of-the-uterine-wall.pdf
Final Published Version
License: Strathprints license 1.0
Download (72kB)| Preview

Abstract

Introduction Despite their prevalence and their profound impact on patient’s lives, chronic gynaecological disorders (such as endometriosis and adenomyosis) remain under-researched. Both to advance our understanding of the cellular behaviours underlying these conditions and to provide new tools for screening of potential therapies, advanced in vitro models are required. 3D patient-derived cultures that mimic the uterine wall, comprising both endometrial and myometrial cell types, are an attractive and unexplored route. Here, we describe an organon-a-chip approach to creating such cultures, demonstrating multiplexed, hormone-responsive uterine models within a microfluidic array. Materials and Methods Endometrial (obtained from pipelle biopsies) and myometrial (from patients undergoing elective C-sections) tissue samples were enzymatically dissociated to produce epithelial, stromal and myometrial cell fractions [1]. These cell suspensions were sequentially seeded into a microfluidic device with multiple, individually addressable channels, each containing a 5x5 microwell array. The devices were fabricated in PDMS and functionalised to create a non-adherent surface as previously published [2]. The resultant 3D cultures were maintained in vitro for up to 15 days and were subjected to hormone stimulation with β-estradiol (E2, 10 nM), medroxyprogesterone acetate (MPA, 100 nM) and cAMP (500 µM). Cellular organisation was monitored by live-cell imaging using fluorescent tracers and by end-point immunocytochemistry (pan-cytokeratin for epithelial cells, calponin for myocytes (SMCs), vimentin for stromal cells), with model functionality assessed by measuring IGFBP-1 and osteopontin secretion (by ELISA) following hormone stimulation. Results and Discussion A series of cell injection protocols, sequentially seeding the three cellular fractions over 2-4 days, were investigated. Regardless of protocol, epithelial cells ultimately localised to the outer periphery of the 3D cultures. Optimum results – where self-organisation resulted in robust 3D cultures with an outer epithelial layer encircling an inner myometrial core, thus mimicking the architecture of the uterine wall – were obtained when the myometrial cells were seeded last and when 5% (v/v) Matrigel® was incorporated into the culture media. Consistent cellular organisation was obtained when directly comparing patient-derived cultures produced from different endometrial biopsies (n=3, all biopsies from secretory phase tissue). Exposure of these cultures to E2, MPA and cAMP resulted in an increase in the secretion of both osteopontin and IGFBP-1, indicating stromal decidualisation [3]. Conclusions These functional, 3D multicellular cultures show promise for personalised modelling of gynaecological disorders, enabling screening of patient-derived cultures in a medium-throughput format.

ORCID iDs

Busch, Caroline, Hill, Christopher J., Paterson, Karla, Zagnoni, Michele ORCID logoORCID: https://orcid.org/0000-0003-3198-9491, Hapangama, Dharani and Sandison, Mairi E. ORCID logoORCID: https://orcid.org/0000-0003-1021-1461;
CORE (COnnecting REpositories)